TenderDekho Logo
GEM

Procurement Opportunity: INJ NOVORAPID,TAB ATORVASTATIN 80 MG,TAB ISOSORBIDE DINITRATE HYDRALZINE37 point 5MG,TAB PREGABALIN in HYDERABAD, TELANGANA

Bid Publish Date

01-May-2025, 10:31 am

Bid End Date

22-May-2025, 11:00 am

Value

₹34,69,414

Progress

RA
Issue01-May-2025, 10:31 am
Reverse Auction26-Jun-2025, 10:00 am
AwardPending
Explore all 5 tabs to view complete tender details

Quantity

573870

Categories 11

Public procurement opportunity for Indian Army INJ NOVORAPID, TAB ATORVASTATIN 80 MG, TAB ISOSORBIDE DINITRATE HYDRALZINE37 point 5MG, TAB PREGABALIN 75 MG METHYLCOBALAMINE 750 MCG, TAB L CARNITINE L TARTATE 500MG METHYLCOBALAMIN 1500MCG FOLIC ACID 15MG, TAB ESOMEPRAZOLE 40 MG DOMPERIDONE 10 MG, TAB DIACERINE 50MG GLUCOSAMINE SULPHATE POTASSIUM CHLORIDE 750MG METHYL SULFONYL METHANE 250MG, TAB EMPAGLIFLOZIN 25MG LINAGLIPTIN 5MG, TAB TENELIGLIPTIN 20 MG, INJ HUMAN INSULIN LISPRO 100IU per ML 3ML CARTIDGE INJECTION INSULIN LISPRO BIPHASIC 100IU per ML, INJ ERYTHROPOIETIN RECOMBINANT HUMAN 6000 IU, TAB CARVEDILOL CR 10 MG, TAB GLIMEPIRIDE 1 MG METFORMIN 500 MG, TAB GLIMEPRIDE 2 MG METFORMIN 500 MG, TAB ESCITALOPARAM CLONAZEPAM, CAP GLUCOSAMINE 500 MG CHONDROITIN SULPHATE 400 MG in HYDERABAD, TELANGANA. Quantity: 573870 issued by. Submission Deadline: 22-05-2025 11: 00: 00. View full details and respond.

Documents 4

GeM-Bidding-7772560.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

BETAHISTINE 16 MG TAB,BISOPROLOL 5MG TAB,BUDESONIDE 0.5 RESPULES,BUVALOR and BUPRENORPHINE PATCH 20

Indian Army

JAMMU, JAMMU & KASHMIR

Posted: 20 December 2024
Closed: 10 January 2025
GEM

Lispro Insulin Inj Pen PFS fifty by fifty,Insulin Inj Pen Aspart 100IU,Metformin 500 mg Tab,Glimepi

Indian Air Force

COIMBATORE, TAMIL NADU

Posted: 29 August 2025
Closed: 13 September 2025
GEM

ARIPIPRAZOLE 5 MG TAB,MESALAMINE 400 GM TAB,CARVEDILOL 12.5 MG TAB,CYPROHEPTADINE 4 MG TAB,DAPAGLIF

Indian Army

PATIALA, PUNJAB

Posted: 11 February 2025
Closed: 4 March 2025
GEM

Indian Air Force Medical Supplies Tender 2026 – Multi-Item Pharmaceutical & Medical Equipment Procurement including Insulin Pens, Glucose Meters, Topical Creams, Cuffs, Zolpidem, Salbutamol Inhalers, and related items

Indian Air Force

Rangareddi, TELANGANA

Posted: 8 February 2026
Closed: 18 February 2026
GEM

Acebrophylline 200 mg Tab,Amlodipine 5 mg plus Metoprolol 50 mg Tab,Baclofen 20 mg Tab,Beclomethaso

Dg Armed Forces Medical Service

JAIPUR, RAJASTHAN

Posted: 20 December 2024
Closed: 10 January 2025
GEM

Bill of Quantities (BOQ) 16 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 INJ NOVORAPID Inj 2,180 pen ms18473f 21
2 TAB ATORVASTATIN 80 MG TAB 9,900 no ms18473f 21
3 TAB ISOSORBIDE DINITRATE HYDRALZINE37 point 5MG TAB 10,800 no ms18473f 21
4 TAB PREGABALIN 75 MG METHYLCOBALAMINE 750 MCG TAB 88,200 no ms18473f 21
5 TAB L CARNITINE L TARTATE 500MG METHYLCOBALAMIN 1500MCG FOLIC ACID 15MG TAB 14,400 no ms18473f 21
6 TAB ESOMEPRAZOLE 40 MG DOMPERIDONE 10 MG TAB 72,000 no ms18473f 21
7 TAB DIACERINE 50MG GLUCOSAMINE SULPHATE POTASSIUM CHLORIDE 750MG METHYL SULFONYL METHANE 250MG TAB 23,400 no ms18473f 21
8 TAB EMPAGLIFLOZIN 25MG LINAGLIPTIN 5MG TAB 2,400 no ms18473f 21
9 TAB TENELIGLIPTIN 20 MG TAB 28,200 no ms18473f 21
10 INJ HUMAN INSULIN LISPRO 100IU per ML 3ML CARTIDGE INJECTION INSULIN LISPRO BIPHASIC 100IU per ML TAB 60 cart ms18473f 21
11 INJ ERYTHROPOIETIN RECOMBINANT HUMAN 6000 IU Inj 70 no ms18473f 21
12 TAB CARVEDILOL CR 10 MG TAB 10,500 no ms18473f 21
13 TAB GLIMEPIRIDE 1 MG METFORMIN 500 MG TAB 117,000 no ms18473f 21
14 TAB GLIMEPRIDE 2 MG METFORMIN 500 MG TAB 108,600 no ms18473f 21
15 TAB ESCITALOPARAM CLONAZEPAM TAB 7,560 no ms18473f 21
16 CAP GLUCOSAMINE 500 MG CHONDROITIN SULPHATE 400 MG TAB 78,600 no ms18473f 21

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Reverse Auction Schedule

Completed

Start

26-Jun-2025, 10:00 am

End

30-Jun-2025, 12:00 pm

Duration: 98 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Frequently Asked Questions

Key insights about TELANGANA tender market

What are the eligibility requirements for participation in this tender?

The eligibility requirements for this tender include being a registered entity in the pharmaceutical sector, demonstrating experience in supplying medications to government institutions, and fulfilling all necessary regulatory compliances. Interested bidders must also show valid certifications and a track record of quality assurance to qualify for participation.

What certifications are required for pharmaceuticals in this tender?

Vendors must possess and provide evidence of essential certifications such as Good Manufacturing Practices (GMP), FDA (or relevant authority) approvals, and any other relevant compliance documents that validate the quality and safety of the pharmaceuticals. Documentation must showcase adherence to national and international standards.

How should documents be submitted for this tender?

Submissions for this tender must be conducted using the designated online procurement system, ensuring that all required documents are attached in accepted formats such as PDF or Word. Bidders should confirm the completeness of their submission to avoid disqualification due to incomplete information.

What is the Earnest Money Deposit (EMD) requirement for this tender?

An Earnest Money Deposit (EMD) is required as part of the bidding process, which is a monetary assurance to confirm the bidder's sincerity. Details regarding the amount and submission process are outlined in the tender documentation to guide prospective bidders.

Are there benefits for MSEs participating in this tender?

There are significant benefits for Micro, Small, and Medium Enterprises (MSEs), including reduced eligibility criteria and potential financial support provided during the bidding and execution phases. This approach aims to encourage participation from smaller entities, fostering a diverse and competitive bidding environment in the pharmaceuticals supply chain.